Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus

Neuroscience Letters

Volumn 345, Issue 2, 2003, Pages 141-143

  Yildirim, Emre ^a   Zhang, Zhijing ^a   Uz, Tolga ^a   Chen, Chang Qing ^a   Manev, Radmila ^a   Manev, Hari ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 Lipoxygenase; Arachidonic acid; Chromatin remodeling; Epigenetic; Histone deacetylase; Leukotriene; Valproic acid

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; PROTEIN; VALPROIC ACID;

ACETYLATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIPOLAR DISORDER; BRAIN; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MODEL; MOUSE; MUTATION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL;

EID: 0038380334     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00490-7     Document Type: Article

References (20)

1. Alonso-Aperte E., Ubeda N., Achon M., Perez-Miguelsanz J., Varela-Moreiras G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology. 52:1999;750-756.
2. Coyle J.T., Manji H.K. Getting balance: drugs for bipolar disorder share target. Nat. Med. 8:2002;557-558.
3. Fry C.J., Peterson C.L. Unlocking the gates to gene expression. Science. 295:2002;1847-1848.
4. Göttlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco C., Pelicci P.G., Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 24:2001;6969-6978.
5. Honack D., Loscher W. Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Epilepsy Res. 13:1992;215-221.
6. Huang Y., Doherty J.J., Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci. 22:2002;8422-8428.
7. Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1:2002;287-299.
8. Manev H., Uz T. DNA hypomethylating agents 5-aza-2′-deoxycitidine and valproate increase neuronal 5-lipoxygenase mRNA. Eur. J. Pharmacol. 445:2002;149-150.
9. Manev H., Uz T., Sugaya K., Qu T. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 14:2000;1464-1469.
10. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry. 48:2000;740-754.
11. Melnick A., Licht J.D. Histone deacetylases as therapeutic targets in hematologic malignancies. Curr. Opin. Hematol. 9:2002;322-332.
12. Novik K.L., Nimmrich I., Genc B., Maier S., Piepenbrock C., Olek A., Beck S. Epigenomics: genome-wide study of methylation phenomena. Curr. Issues Mol. Biol. 4:2002;111-128.
13. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276:2001;36734-36741.
14. Rea S., Eisenhaber F., O'Carroll D., Strahl B.D., Sun Z.-W., Schmid M., Opravil S., Mechtler K., Ponting C.P., Allis C.D., Jenuwein T. Regulation of chromatin structure by site-specific histone H3 methyltransferase. Nature. 406:2000;593-599.
15. Timmermann S., Lehrmann H., Polesskaya A., Harel-Bellan A. Histone acetylation and disease. Cell. Mol. Life Sci. 58:2001;728-736.
16. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. USA. 99:2002;17095-17100.
17. Uhl J., Klan N., Rose M., Entian K.D., Werz O., Steinhilber D. The 5-lipoxygenase promoter is regulated by DNA methylation. J. Biol. Chem. 277:2002;4374-4379.
18. Uz T., Manev R., Manev H. 5-Lipoxygenase is required for proliferation of immature cerebellar granule neurons in vitro. Eur. J. Pharmacol. 418:2001;15-22.
19. Uz T., Dimitrijevic N., Tueting P., Manev H. 5-Lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor. Neurol. Neurosci. 20:2002;15-20.
20. Williams R.S., Cheng L., Mudge A.W., Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature. 417:2002;292-295.